Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 19 analysts with 12-month price forecasts for Apellis Pharmaceuticals stock had an average target of $35.53, with a low estimate of $18 and a high estimate of $52.

Price Target: $35.53 (-13.40%)

Analyst Consensus: Hold

Price Target

Target	Low	Average	Median	High
Price	$18	$35.53	n/a	$52
Change	-56.13%	-13.40%	n/a	+26.74%

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock from 19 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

885.09M

from 1.00B

-11.82%

from 1.00B

Revenue Next Year

1.05B

from 885.09M

18.29%

from 885.09M

EPS This Year

-1.18

from 0.17

EPS Next Year

-0.25

from -1.18

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	66.56M	75.42M	396.59M	781.37M	1.00B	885.09M	1.05B
Revenue Growth	-73.44%	13.31%	425.83%	97.02%	28.47%	-11.82%	18.29%
EPS	-8.84	-6.15	-4.45	-1.60	0.17	-1.18	-0.25
No. Analysts	-	-	-	-	-	23	23

Revenue Forecast

Revenue	2026	2027
High	1.0B	1.2B
Avg	885.1M	1.0B
Low	778.6M	855.6M

Revenue Growth

Revenue Growth	2026	2027
High	-0.1%	40.0%
Avg	-11.8%	18.3%
Low	-22.4%	-3.3%

EPS Forecast

EPS	2026	2027
High	-0.40	1.05
Avg	-1.18	-0.25
Low	-2.15	-1.98

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-